PTGS2 and Alzheimer disease: Thus, the characteristic feature of AD is chronic and sustained microglia activation which results in increasing inflammatory mediators, such as cyclooxygenase-2 (COX-2), nitric oxide (NO), tumour necrosis factor α (TNF-α), and interleukin 1B (IL-1B).